Yu-Hsin Lin | executive |
Nathan Mata | executive |
Hao-Yuan Chuang | analyst |
Jennifer Kim | analyst |
Basma Radwan Ibrahim | analyst |
Yi Chen | analyst |
Bruce Jackson | analyst |
Hello, and thank you for joining us to discuss Belite's Third Quarter 2023 Financial Results.
Joining the call is Dr. Tom Lin, Chairman and CEO; Dr. Nathan Mata, Chief Scientific Officer; and Hao-Yuan Chuang, Chief Financial Officer of Belite Bio.Before we begin, let me point out that we will be making forward-looking statements that are based on current expectations and beliefs. These statements are subject to certain risks and uncertainties, and actual results may differ materially.